Home / Articles / Discovery of diarylphosphoryl and diaminophosphoryl substituted 1,3,4-thiadiazoles for combination therapy of breast cancer
JUST ACCEPTED ARTICLE. This article has been peer-reviewed and accepted for publication. It is citable and carries a permanent DOI. This version has not been copyedited or typeset and will be replaced by the final version of record.

Discovery of diarylphosphoryl and diaminophosphoryl substituted 1,3,4-thiadiazoles for combination therapy of breast cancer

D. Yu. Uvarov 1, 
D. Yu. Uvarov
A. M. Scherbakov 2, 3, 
A. M. Scherbakov
D. I. Salnikova 1, 2, 3, 
D. I. Salnikova
T. A. Bogush 2, 
T. A. Bogush
I. V. Zavarzin 1, 
I. V. Zavarzin
Yu. A. Volkova 1*
Yu. A. Volkova
Published 6 November 2026 , received 8 June 2026
Communication
0
Cite this
GOST
 | 
Cite this
GOST
Uvarov D. Y. et al. Discovery of diarylphosphoryl and diaminophosphoryl substituted 1,3,4-thiadiazoles for combination therapy of breast cancer // Mendeleev Communications. 2026.
GOST all authors (up to 50)
Uvarov D. Y., Scherbakov A. M., Salnikova D. I., Bogush T. A., Zavarzin I. V., Volkova Y. A. Discovery of diarylphosphoryl and diaminophosphoryl substituted 1,3,4-thiadiazoles for combination therapy of breast cancer // Mendeleev Communications. 2026.
RIS
 | 
Cite this
RIS
TY - JOUR
DO - 10.71267/mencom.8115
UR - https://mendcomm.colab.ws/publications/10.71267/mencom.8115
TI - Discovery of diarylphosphoryl and diaminophosphoryl substituted 1,3,4-thiadiazoles for combination therapy of breast cancer
T2 - Mendeleev Communications
AU - Uvarov, D. Yu.
AU - Scherbakov, A. M.
AU - Salnikova, D. I.
AU - Bogush, T. A.
AU - Zavarzin, I. V.
AU - Volkova, Yu. A.
PY - 2026
DA - 2026/11/06
PB - Mendeleev Communications
ER -
BibTex
Cite this
BibTex (up to 50 authors)
@article{2026_Uvarov,
author = {D. Yu. Uvarov and A. M. Scherbakov and D. I. Salnikova and T. A. Bogush and I. V. Zavarzin and Yu. A. Volkova},
title = {Discovery of diarylphosphoryl and diaminophosphoryl substituted 1,3,4-thiadiazoles for combination therapy of breast cancer},
journal = {Mendeleev Communications},
year = {2026},
publisher = {Mendeleev Communications},
month = {Nov},
url = {https://mendcomm.colab.ws/publications/10.71267/mencom.8115},
doi = {10.71267/mencom.8115}
}
Views / Downloads
17 / 8

Abstract

Compound (4-bromophenyl)-1,3,4-thiadiazol-N,N'-diphenylphosphonic diamide 3j exhibited the promising antiproliferative activity against MCF-7 breast cancer cells, with an IC50 of 26 µM. Combination studies revealed that compound 3j acts synergistically with several clinically relevant anticancer agents, including an AKT inhibitor, everolimus, docetaxel, doxorubicin, and 4-hydroxytamoxifen, as evidenced by high synergy scores in MCF-7 cells.

Keywords

antiproliferative agents
cancer
Heterocycles
organophosphorus compounds
thiadiazole

Funders

Russian Science Foundation
22-13-00161-P